|
業務類別
|
-- |
|
業務概覽
|
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites. |
| 公司地址
| Krogshoejvej 36, Bagsvaerd, DNK, 2880 |
| 電話號碼
| +45 44460000 |
| 傳真號碼
| +45 44469999 |
| 公司網頁
| https://www.novonesis.com |
| 員工數量
| 11641 |
| Ms. Ester Baiget |
President and Chief Executive Officer |
-- |
25/02/2026 |
| Mr. Rainer Lehmann |
Executive Vice President and Chief Financial Officer |
-- |
25/02/2026 |
|
|
| Ms. Kim Stratton |
Independent Director |
25/02/2026 |
| Ms. Monila Kothari |
Independent Director |
25/02/2026 |
| Mr. Preben Nielsen |
Director |
25/02/2026 |
| Mr. Robert Noddeskov Jensen |
Director |
25/02/2026 |
| Ms. Lise Kaae |
Independent Director |
25/02/2026 |
| Mr. Heine Dalsgaard |
Vice Chairman of the Board |
25/02/2026 |
| Mr. Cees de Jong |
Chairman of the Board |
25/02/2026 |
| Mr. Kevin Lane |
Independent Director |
25/02/2026 |
| Mr. Lars Bo Koppler |
Director |
25/02/2026 |
| Ms. Frederikke Rose Spenner |
Director |
25/02/2026 |
| Mr. Kasim Kutay |
Director |
25/02/2026 |
| Mr. Morten Otto Alexander Sommer |
Independent Director |
25/02/2026 |
|
|
|
|
